×

Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-HT;serotonin receptor

  • US 9,199,940 B2
  • Filed: 07/03/2013
  • Issued: 12/01/2015
  • Est. Priority Date: 05/18/2006
  • Status: Active Grant
First Claim
Patent Images

1. A crystalline form of 4-(2-(4-(3-methoxybenzamido)-2-(1-methyl-1H-pyrazol-5-yl)phenoxy)ethyl)morpholin-4-ium chloride (Form I) having an X-ray powder diffraction pattern, generated with CuKα

  • radiation, comprising a peak, in terms of 2 θ

    , at about 14.4°

    .

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×